Germline Testing for Patients With BRCA1/2 Mutations on Somatic Tumor Testing

BACKGROUND: The National Comprehensive Cancer Network (NCCN) recommends germline testing for pathogenic BRCA1/2 mutations identified by somatic tumor sequencing. The aim of this study was to explore whether patients at Stanford with somatic BRCA1/2 mutations were recommended germline testing in acco...

Descripción completa

Detalles Bibliográficos
Autores principales: Vlessis, Katherine, Purington, Natasha, Chun, Nicolette, Haraldsdottir, Sigurdis, Ford, James M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7043298/
https://www.ncbi.nlm.nih.gov/pubmed/32259017
http://dx.doi.org/10.1093/jncics/pkz095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7043298/
https://www.ncbi.nlm.nih.gov/pubmed/32259017
http://dx.doi.org/10.1093/jncics/pkz095

Ejemplares similares